Chemotherapeutic evaluation of a synthetic tubulysin analogue-dendrimer conjugate in c26 tumor bearing mice.
作者信息
Floyd William C, Datta Gopal K, Imamura Shinichi, Kieler-Ferguson Heidi M, Jerger Katherine, Patterson Andrew W, Fox Megan E, Szoka Francis C, Fréchet Jean M J, Ellman Jonathan A
机构信息
University of California, Berkeley, 94720-1460, USA.
出版信息
ChemMedChem. 2011 Jan 3;6(1):49-53. doi: 10.1002/cmdc.201000377.
Abstract
摘要
相似文献
1
Chemotherapeutic evaluation of a synthetic tubulysin analogue-dendrimer conjugate in c26 tumor bearing mice.
ChemMedChem. 2011 Jan 3;6(1):49-53. doi: 10.1002/cmdc.201000377.
2
Design, synthesis, and biological evaluation of a robust, biodegradable dendrimer.
Bioconjug Chem. 2010 Apr 21;21(4):764-73. doi: 10.1021/bc900553n.
3
Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin.
J Inorg Biochem. 2011 Sep;105(9):1115-22. doi: 10.1016/j.jinorgbio.2011.05.017. Epub 2011 May 27.
4
BR2 and CyLoP1 enhance in-vivo SN38 delivery using pegylated PAMAM dendrimers.
Int J Pharm. 2019 Jun 10;564:77-89. doi: 10.1016/j.ijpharm.2019.04.037. Epub 2019 Apr 13.
5
N-acetyl-d-glucosamine-conjugated PAMAM dendrimers as dual receptor-targeting nanocarriers for anticancer drug delivery.
Eur J Pharm Biopharm. 2020 Sep;154:377-386. doi: 10.1016/j.ejpb.2020.07.020. Epub 2020 Jul 25.
6
In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
J Nanobiotechnology. 2016 Jun 13;14(1):45. doi: 10.1186/s12951-016-0197-6.
7
A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas.
Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16649-54. doi: 10.1073/pnas.0607705103. Epub 2006 Oct 30.
8
Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
Int J Pharm. 2017 Mar 15;519(1-2):352-364. doi: 10.1016/j.ijpharm.2017.01.044. Epub 2017 Jan 23.
9
Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates.
Mol Pharm. 2009 Sep-Oct;6(5):1562-72. doi: 10.1021/mp9001206.
10
Preparation, characterization and in-vivo evaluation of microemulsions containing tamoxifen citrate anti-cancer drug.
Eur J Pharm Sci. 2017 Jan 1;96:479-489. doi: 10.1016/j.ejps.2016.09.033. Epub 2016 Sep 28.
引用本文的文献
1
Structural recognition of tubulysin B derivatives by multidrug resistance efflux transporters in human cancer cells.
Oncotarget. 2017 Jul 25;8(30):49973-49987. doi: 10.18632/oncotarget.18385.
本文引用的文献
1
Polymer-Based Therapeutics.
Macromolecules. 2009 Jan 13;42(1):3-13. doi: 10.1021/ma801782q.
2
Design, synthesis, and biological evaluation of a robust, biodegradable dendrimer.
Bioconjug Chem. 2010 Apr 21;21(4):764-73. doi: 10.1021/bc900553n.
3
Discovery of 23 natural tubulysins from Angiococcus disciformis An d48 and Cystobacter SBCb004.
Chem Biol. 2010 Mar 26;17(3):296-309. doi: 10.1016/j.chembiol.2010.01.016.
4
Toward tubulysin: gram-scale synthesis of tubuvaline-tubuphenylalanine fragment.
J Org Chem. 2009 Dec 18;74(24):9531-4. doi: 10.1021/jo9015503.
5
First total synthesis of tubulysin B.
Org Lett. 2009 Dec 17;11(24):5567-9. doi: 10.1021/ol902320w.
6
In vivo structural activity and optimization studies of folate-tubulysin conjugates.
Mol Pharm. 2009 Sep-Oct;6(5):1518-25. doi: 10.1021/mp900086w.
7
Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates.
Mol Pharm. 2009 Sep-Oct;6(5):1562-72. doi: 10.1021/mp9001206.
8
Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture.
Acc Chem Res. 2009 Aug 18;42(8):1141-51. doi: 10.1021/ar900035f.
9
Dendrimers as carriers for delivery of chemotherapeutic agents.
Chem Rev. 2009 Jul;109(7):3141-57. doi: 10.1021/cr900174j.
10
Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-l-lysine dendrimers.
Mol Pharm. 2009 Jul-Aug;6(4):1190-204. doi: 10.1021/mp900049a.
Zotero 插件